EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders

Core Viewpoint - The investigation by Halper Sadeh LLC focuses on the fairness of the acquisition of Evoke Pharma, Inc. by QOL Medical, LLC at a price of $11.00 per share in cash for Evoke shareholders [1] Company Summary - Evoke Pharma, Inc. is being sold to QOL Medical, LLC for $11.00 per share in cash [1] - The law firm Halper Sadeh LLC is investigating the transaction to determine if it is fair to Evoke shareholders [1]